Chemical Structure : Selpercatinib
CAS No.: 2152628-33-4
Catalog No.: PC-60209Not For Human Use, Lab Use Only.
Selpercatinib (LOXO-292, LOXO292) is a potent, selective, orally available RET kinase inhibitor with IC50 of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M), and RET (G810R), respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $98 | In stock | |
25 mg | $158 | In stock | |
50 mg | $248 | In stock | |
100 mg | $388 | In stock | |
250 mg | Get quote | ||
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Selpercatinib (LOXO-292, LOXO292) is a potent, selective, orally available RET kinase inhibitor with IC50 of 14.0 nM, 24.1 nM, and 530.7 nM for RET (WT), RET (V804M), and RET (G810R), respectively.
LOXO-292 displays >100-fold selectivity versus important off-targets.
LOXO-292 shows anti-tumor activty in the brain and periphery in RET-dependent tumor models in vivo.
M.Wt | 525.613 | |
Formula | C29H31N7O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile |
1. Subbiah V, et al. Ann Oncol. 2018 Aug 1;29(8):1869-1876.
2. Cancer Discov. 2018 Aug;8(8):904-905.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright